Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact of Continuing Medical Education (CME) Insulin Program

This study has been completed.
International Diabetes Center at Park Nicollet
Eli Lilly and Company
Novo Nordisk A/S
United Health Care
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
HealthPartners Institute Identifier:
First received: January 15, 2009
Last updated: November 30, 2015
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)